Candelanza, Mary Joy M.
HRN: 19-41-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/26/2025
10/03/2025
IVTT
4.5g
Q6H
CAP-MR
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines